TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
TVTX

Travere Therapeutics Inc

Healthcare · Biotechnology

52.00$ -2.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Travere Therapeutics Inc (TVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 799 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TVTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
833 789 664 551 504 594 549 555 539 605 555 799
686 617 481 369 325 417 374 380 371 438 393 615
144 58 43 32 36 59 62 75 111 93 78 118
635 567 441 325 277 371 322 320 255 323 265 489
15 21 23 24 25 27 34 39 83 81 87 81
21 9.4 4.5 6.0 6.4 6.2 3.9 4.1 5.5 5.9 6.4 7.8
0.8 0.8 0.8 0.8 0.7 0.8 0.8 0.8 0.8 0.8 0.8 –
106 104 100 104 103 103 103 105 109 113 109 132
553 588 589 536 535 535 516 523 465 490 456 775
139 178 173 121 190 201 182 190 135 160 125 152
4.8 4.9 5.0 5.2 74 74 74 74 5.7 5.9 6.0 6.2
25 42 17 26 23 24 15 19 18 25 13 7.5
377 377 378 378 310 310 311 311 311 312 312 603
280 201 74 15 -30 59 33 33 74 115 99 25
-1,035 -1,126 -1,262 -1,332 -1,387 -1,447 -1,488 -1,501 -1,475 -1,473 -1,510 -1,545
76 76 77 78 78 83 88 89 103 90 92 93

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?